Organon & Co (OGN) earnings · rev $6.22B
These earnings events as JSON? API free 100/dayOrganon & Co (OGN) is a drug manufacturers - general company listed on US.
This OGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported OGN revenue for 2025-12-31 was $6.22B. Net income was $187.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OGN currently screens at market cap $2.52B.
When the next OGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 2.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full OGN research stays on the stock page; the tape stays on the quote page.
OGN earnings FAQ
What are OGN's latest revenue and net income?
Latest cached Organon & Co (OGN) revenue for Dec 31, 2025 was $6.22B. Net income was $187.0M. Statements: https://lician.com/financials/ogn
What is OGN's latest diluted EPS?
Latest cached Organon & Co (OGN) diluted EPS for Dec 31, 2025 was $0.72.
What period does the latest OGN earnings print cover?
The latest cached Organon & Co (OGN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did OGN revenue change from the prior cached period?
Cached Organon & Co (OGN) revenue was down 2.9% from $6.40B (Dec 31, 2024) to $6.22B (Dec 31, 2025). Statements: https://lician.com/financials/ogn
Where are OGN earnings listed?
Cached earnings facts for Organon & Co (OGN) are listed at https://lician.com/earnings/ogn. Statements: https://lician.com/financials/ogn
Not investment advice.